ARRIS Group (ARRS): Raising PT On Reduced Risk Of STB Proposal - Needham
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
Needham & Company analyst, Richard Valera, reiterated his Buy rating on shares of ARRIS Group (NASDAQ: ARRS) and raised the price target to $35 after hosting the VP of Investor Relations, Bob Puccini, for a series of investor meetings.
The most notable incremental takeaways include the likely end of the FCC app-based STB
proposal and a clearer view of the company's capital allocation strategy, which appears
to have tilted toward M&A. The analyst thinks ARRS is well positioned to take advantage of a multi-year network upgrade cycle by its MSO customers, and we view the likely demise of the FCC proposal as serving to de-risk the long-term outlook of the company's STB business.
The new $35 increase from $32 is based on 11.8x C'17 EPS and reflects reduced risk from the FCC's STB proposal.
Shares of ARRIS Group closed at $29.17 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- M&T Bank (MTB) PT Raised to $165 at FBR Capital Following 4Q Beat
- Skyworks Solutions (SWKS) PT Raised to $92 at Needham & Company Following Solid 1Q Beat and Raise
- Union Pacific (UNP) PT Raised to $120 at Aegis Capital Following Solid 4Q
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst PT Change, Management Changes
Related EntitiesNeedham & Company
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!